Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 4 Other hematologic neoplasm 1 Breast 1

Conditions

Breast Neoplasms 54 Colorectal Neoplasms 10 Uterine Cervical Neoplasms 6 Prostatic Neoplasms 6 Breast Carcinoma In Situ 6 Ovarian Neoplasms 5 Neoplasms 5 Lung Neoplasms 5 Colonic Neoplasms 5 Triple Negative Breast Neoplasms 4 Endometrial Neoplasms 4 Depression 4 Vulvar Neoplasms 3 Urinary Bladder Neoplasms 3 Rectal Neoplasms 3 Obesity 3 Motor Activity 3 Lymphoma 3 Carcinoma, Intraductal, Noninfiltrating 3 Anxiety Disorders 3 Anatomic Stage I Breast Cancer AJCC v8 3 Vaginal Neoplasms 2 Pancreatic Neoplasms 2 Melanoma 2 Lymphedema 2 Leukemia 2 Kidney Neoplasms 2 Genital Neoplasms, Female 2 Fatigue 2 Weight Loss 1

Interventions

Paclitaxel 50 Capecitabine 50 Trastuzumab 38 Fulvestrant 31 Cyclophosphamide 27 pembrolizumab 26 Carboplatin 26 Gemcitabine 23 Letrozole 21 palbociclib 19 Docetaxel 19 Lapatinib 18 Bevacizumab 18 exemestane 17 eribulin 15 Everolimus 14 abemaciclib 13 Vinorelbine 13 Nivolumab 13 Magnetic Resonance Spectroscopy 12 Anastrozole 12 trastuzumab deruxtecan 11 Zoledronic Acid 11 Doxorubicin 11 Cisplatin 11 Albumin-Bound Paclitaxel 11 olaparib 10 Tamoxifen 10 Specimen Handling 10 Radiotherapy 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm Metastasis × Methods × Breast × Clear all

NCT02251353 2020-02-21

IMET

Federation of Breast Diseases Societies

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡